Satellite Cell Proliferation via Kinase and HDAC Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for compositions and methods to enhance satellite cell proliferation, which is crucial for muscle growth and repair, particularly in conditions like Duchenne muscular dystrophy and sarcopenia where satellite cells are depleted or inefficient, affecting muscle wasting and recovery.
Innovation Solution
The method involves contacting satellite cells with compounds such as kinase inhibitors, G protein coupled receptor modulators, histone deacetylase modulators, hedgehog signaling pathway modulators, neuropeptides, dopamine receptor modulators, serotonin receptor modulators, histamine receptor modulators, adenosine receptor agonists, ionophores, and ion channel modulators to increase proliferation without affecting differentiation potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If satellite cells are depleted or their proliferative capacity is reduced due to aging or disease, then muscle repair and growth efficiency deteriorates, but administering compounds to enhance proliferation may adversely affect cell differentiation potential
Solution Approach 1:
The patent employs small molecules that modulate specific signaling pathways (such as mTOR, PI3K/Akt, and MAPK) to change the physiological parameters of satellite cells. These compounds selectively enhance proliferative signals while maintaining differentiation capacity by regulating pathway activation thresholds and temporal dynamics, thus resolving the contradiction between increased proliferation and preserved differentiation potential
Solution Approach 2:
The patent uses small molecule compounds as intermediaries that selectively target and modulate specific intracellular signaling pathways. These intermediaries act as mediators to decouple the proliferation and differentiation processes, allowing enhancement of one without adversely affecting the other by targeting pathway crosstalk points and regulatory nodes
2Object-generated harmful factors
If conventional therapies are used to treat muscle wasting diseases, then some symptomatic relief may be achieved, but they fail to address the underlying satellite cell depletion and proliferative deficiency
Solution Approach 1:
The patent extracts and targets the specific molecular mechanisms controlling satellite cell proliferation (such as cyclin-dependent kinases, mTOR signaling, and growth factor receptors) from the complex pathology of muscle wasting diseases. By isolating and modulating these specific pathways with selective small molecules, the treatment addresses the root cause of regenerative failure rather than merely managing symptoms
Solution Approach 2:
Instead of attempting to protect or preserve existing satellite cells, the patent inverts the approach by actively stimulating proliferation of the residual satellite cell pool through pharmacological activation of growth-promoting pathways. This inverse strategy converts the depleted state into an expanding state by targeting the proliferative capacity that remains
Data Source
AI summary
The invention provides methods for inducing, enhancing or increasing satellite cell proliferation, and an assay for screening for a candidate compound for inducing, enhancing or increasing satellite cell proliferation. Also provided are methods for repairing or regenerating a damaged muscle tissue of a subject.